JP2009232836A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009232836A5 JP2009232836A5 JP2008294361A JP2008294361A JP2009232836A5 JP 2009232836 A5 JP2009232836 A5 JP 2009232836A5 JP 2008294361 A JP2008294361 A JP 2008294361A JP 2008294361 A JP2008294361 A JP 2008294361A JP 2009232836 A5 JP2009232836 A5 JP 2009232836A5
- Authority
- JP
- Japan
- Prior art keywords
- base sequence
- dna
- seq
- sequence shown
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700618 Vaccinia virus Species 0.000 claims 12
- 241000711549 Hepacivirus C Species 0.000 claims 8
- 230000000295 complement effect Effects 0.000 claims 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 239000002299 complementary DNA Substances 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 208000005176 Hepatitis C Diseases 0.000 claims 2
- 101710172711 Structural protein Proteins 0.000 claims 1
- 206010046865 Vaccinia virus infection Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 208000007089 vaccinia Diseases 0.000 claims 1
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008294361A JP5584407B2 (ja) | 2008-03-07 | 2008-11-18 | Ｃ型肝炎ウイルス遺伝子を有する組換えワクシニアウイルス |
| ES09717492.4T ES2573704T3 (es) | 2008-03-07 | 2009-03-06 | Virus de la variolovacuna recombinante que tiene el gen del virus de la hepatitis C |
| CN200980107538XA CN101965396B (zh) | 2008-03-07 | 2009-03-06 | 具有丙型肝炎病毒基因的重组痘苗病毒 |
| US12/736,079 US9000136B2 (en) | 2008-03-07 | 2009-03-06 | Recombinant vaccinia virus having hepatitis C virus gene |
| KR1020107022452A KR101607349B1 (ko) | 2008-03-07 | 2009-03-06 | Ｃ 형 간염 바이러스 유전자를 갖는 재조합 백시니아 바이러스 |
| PCT/JP2009/054825 WO2009110644A1 (ja) | 2008-03-07 | 2009-03-06 | C型肝炎ウイルス遺伝子を有する組換えワクシニアウイルス |
| AU2009220401A AU2009220401B2 (en) | 2008-03-07 | 2009-03-06 | Recombinant vaccinia virus having hepatitis C virus gene |
| EP09717492.4A EP2267120B1 (en) | 2008-03-07 | 2009-03-06 | Recombinant vaccinia virus having hepatitis c virus gene |
| CA2717626A CA2717626A1 (en) | 2008-03-07 | 2009-03-06 | Recombinant vaccinia virus having hepatitis c virus gene |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008057515 | 2008-03-07 | ||
| JP2008057515 | 2008-03-07 | ||
| JP2008294361A JP5584407B2 (ja) | 2008-03-07 | 2008-11-18 | Ｃ型肝炎ウイルス遺伝子を有する組換えワクシニアウイルス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009232836A JP2009232836A (ja) | 2009-10-15 |
| JP2009232836A5 true JP2009232836A5 (enExample) | 2012-01-05 |
| JP5584407B2 JP5584407B2 (ja) | 2014-09-03 |
Family
ID=41056188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008294361A Expired - Fee Related JP5584407B2 (ja) | 2008-03-07 | 2008-11-18 | Ｃ型肝炎ウイルス遺伝子を有する組換えワクシニアウイルス |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9000136B2 (enExample) |
| EP (1) | EP2267120B1 (enExample) |
| JP (1) | JP5584407B2 (enExample) |
| KR (1) | KR101607349B1 (enExample) |
| CN (1) | CN101965396B (enExample) |
| AU (1) | AU2009220401B2 (enExample) |
| CA (1) | CA2717626A1 (enExample) |
| ES (1) | ES2573704T3 (enExample) |
| WO (1) | WO2009110644A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101913553B1 (ko) | 2010-10-15 | 2018-11-05 | 고에키자이단호진 도쿄도 이가쿠 소고겐큐쇼 | 신형 인플루엔자 바이러스 유래 헤마글루티닌 단백질 유전자를 갖는 재조합 백시니아 바이러스 |
| EP2950817B1 (en) * | 2013-01-31 | 2019-08-07 | Portland State University | Immunogenic compositions comprising silicified virus and methods of use |
| WO2014162031A1 (es) * | 2013-04-02 | 2014-10-09 | Consejo Superior De Investigaciones Científicas (Csic) | Vectores recombinantes basados en el virus modificado de ankara (mva) como vacunas preventivas y terapéuticas contra la hepatitis c |
| ES2869575T3 (es) * | 2014-11-11 | 2021-10-25 | Nobelpharma Co Ltd | Composición farmacéutica para el tratamiento y/o la prevención de la hepatitis C |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06237773A (ja) | 1992-12-22 | 1994-08-30 | Tonen Corp | ポックスウイルスのａ型封入体（ａｔｉ）プロモーター及び前期プロモーターを含んで成る外来遺伝子発現ベクター |
| JP2003064096A (ja) * | 2001-08-29 | 2003-03-05 | Mitsubishi Kagaku Bio-Clinical Laboratories Inc | Ｃ型肝炎ウイルス特異的細胞障害性ｔ細胞認識エピトープ |
| DE10143490C2 (de) * | 2001-09-05 | 2003-12-11 | Gsf Forschungszentrum Umwelt | Rekombinantes MVA mit der Fähigkeit zur Expression von HCV Struktur-Antigenen |
| FR2855758B1 (fr) * | 2003-06-05 | 2005-07-22 | Biomerieux Sa | Composition comprenant la polyproteine ns3/ns4 et le polypeptide ns5b du vhc, vecteurs d'expression incluant les sequences nucleiques correspondantes et leur utilisation en therapeutique |
| EP1710300A4 (en) * | 2003-12-05 | 2007-10-24 | Hokkaido Tech Licensing Office | HIGHLY SAFE POX VACCINE VIRUS AND VACCINIA VIRUS VECTOR |
| KR101154278B1 (ko) * | 2004-02-20 | 2012-06-21 | 도레이 카부시키가이샤 | 인간 ｃ형간염 바이러스의 전체 길이 게놈을 함유하는 핵산 구축물 및 상기 핵산 구축물을 도입한 재조합형 전체 길이 바이러스 게놈 복제세포, 및 ｃ형간염 바이러스 입자의 제조방법 |
| JPWO2006013815A1 (ja) * | 2004-08-02 | 2008-05-01 | 財団法人ヒューマンサイエンス振興財団 | ＨＣＶウイルスタンパク質をコードするＤＮＡを保有する組換えワクチニアウイルスＤＩｓ株、およびその利用 |
| JP4665122B2 (ja) * | 2004-10-08 | 2011-04-06 | 財団法人 東京都医学研究機構 | 組み換えウイルスおよびその用途 |
| JP2008057515A (ja) | 2006-09-04 | 2008-03-13 | Mitsubishi Heavy Ind Ltd | ピックアップセンサの出力電圧判定方法および装置 |
| JP5103058B2 (ja) | 2007-05-28 | 2012-12-19 | 株式会社日立ハイテクノロジーズ | 欠陥観察装置及び欠陥観察方法 |
-
2008
- 2008-11-18 JP JP2008294361A patent/JP5584407B2/ja not_active Expired - Fee Related
-
2009
- 2009-03-06 ES ES09717492.4T patent/ES2573704T3/es active Active
- 2009-03-06 CA CA2717626A patent/CA2717626A1/en not_active Abandoned
- 2009-03-06 KR KR1020107022452A patent/KR101607349B1/ko not_active Expired - Fee Related
- 2009-03-06 WO PCT/JP2009/054825 patent/WO2009110644A1/ja not_active Ceased
- 2009-03-06 US US12/736,079 patent/US9000136B2/en not_active Expired - Fee Related
- 2009-03-06 CN CN200980107538XA patent/CN101965396B/zh not_active Expired - Fee Related
- 2009-03-06 EP EP09717492.4A patent/EP2267120B1/en not_active Not-in-force
- 2009-03-06 AU AU2009220401A patent/AU2009220401B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3581650T3 (fi) | IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi | |
| JP2019530462A5 (enExample) | ||
| JP2018520997A5 (enExample) | ||
| NZ592082A (en) | Promoters for recombinant viral expression | |
| JP2004511201A5 (enExample) | ||
| JP2009268467A5 (enExample) | ||
| JP2012136542A5 (enExample) | ||
| JP2009523422A5 (enExample) | ||
| JP2012532601A5 (enExample) | ||
| WO2005014806A3 (en) | Conserved hbv and hcv sequences useful for gene silencing | |
| JP2012095652A5 (enExample) | ||
| WO2009039248A3 (en) | Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection | |
| WO2010107739A3 (en) | Methods and compositions of treating a flaviviridae family viral infection | |
| JP2004512020A5 (enExample) | ||
| CY1106883T1 (el) | Ανασυνδυασμενος ιος ευλογιας που περιεχει τουλαχιστον δυο υποκινητες ατι ιου ευλογιας αγελαδας. | |
| JP2011528895A5 (enExample) | ||
| DE602005026545D1 (de) | Modifizierte genomische rna des menschlichen hepatitis-c-virus mit autonomer replikationskompetenz | |
| JP2007527244A5 (enExample) | ||
| JP2012515557A5 (enExample) | ||
| EP2527445A3 (en) | Treatment and prevention of influenza | |
| WO2010093843A3 (en) | Hcv combination therapies comprising pegylated interferon, ribavirin and telaprevir | |
| JP2009232836A5 (enExample) | ||
| JP2018537089A5 (enExample) | ||
| JP2003503355A5 (enExample) | ||
| JP2014504297A5 (enExample) |